Vitalhub (TSE:VHI – Get Free Report) had its price target cut by analysts at Scotia from C$12.00 to C$9.00 in a report issued on Monday, BayStreet reports. The brokerage currently has a “sector outperform” rating on the stock. Scotia‘s target price would indicate a potential upside of 38.04% from the company’s previous close.
VHI has been the subject of a number of other reports. TD decreased their price target on shares of Vitalhub from C$13.00 to C$9.50 and set a “buy” rating for the company in a research report on Monday. ATB Cormark Capital Markets cut their price objective on Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating on the stock in a research report on Monday. Finally, Canaccord Genuity Group set a C$15.00 price objective on Vitalhub and gave the company a “buy” rating in a research report on Friday, August 28th. Nine equities research analysts have rated the stock with a Buy rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of C$10.86.
Vitalhub Stock Down 6.9%
Shares of Vitalhub stock traded down C$0.48 during trading hours on Monday, hitting C$6.52. The company’s stock had a trading volume of 481,442 shares, compared to its average volume of 297,780. Vitalhub has a 1-year low of C$6.46 and a 1-year high of C$9.77. The business has a fifty day moving average of C$7.56 and a 200 day moving average of C$7.58. The company has a market capitalization of C$412.97 million, a PE ratio of 54.33, a P/E/G ratio of 1.18 and a beta of 1.37.
Vitalhub (TSE:VHI – Get Free Report) last issued its earnings results on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. The business had revenue of C$31.91 million for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. On average, sell-side analysts anticipate that Vitalhub will post 0.23 earnings per share for the current fiscal year.
Vitalhub Company Profile
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
See Also
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
